Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 29;4(19):4607–4617. doi: 10.1182/bloodadvances.2020002604

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by The American Society of Hematology

PMC Copyright notice

Figure 2. — Prebiotics decrease the cumulative incidence of aGVHD. (A) The cumulative incidence of all grades of aGVHD was significantly lower in the prebiotics group than in the historical control group. (B) The cumulative incidence of grades 2 to 4 aGVHD was significantly lower in the prebiotics group than in the historical control group. (C) The cumulative incidence of grades 3 and 4 aGVHD tended to be lower in the prebiotics group than in the historical control group although the difference was not significant. (D-E) The cumulative incidence of all-stage skin aGVHD, and stage 3 and higher aGVHD was significantly lower in the prebiotics group than in the historical control group. (F-G) The cumulative incidence of the gut and lower gut aGVHD tended to be lower in the prebiotics group than in the historical control group, although the difference was not significant. (H) The cumulative incidence of the liver aGVHD did not differ between the prebiotics and historical control groups.